Price Alert

AC Immune S.A. (ACIU)

NASDAQ: ACIU · Real-Time Price · USD

2.15

0.02 (0.94%)

At close: Aug 15, 2025, 3:59 PM

2.12

-1.17%

After-hours: Aug 15, 2025, 04:45 PM EDT

AC Immune S.A. Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	19.96M	36.27M	32.42M	51.56M	57.01M	78.49M	31.93M	40.01M	57.43M	31.59M	44.5M	63.15M	57.84M	82.22M	93.58M	104.14M	151.09M
Short-Term Investments	125.65M	129.21M	125.48M	123.56M	47.81M	24.55M	48M	53M	48M	91M	96M	91M	116M	116M	95M	95M	65M
Long-Term Investments	585K	415K	415K	415K	415K	361K	361K	361K	361K	361K	361K	361K	363K	363K	363K	363K	334K
Other Long-Term Assets	n/a	n/a	n/a	n/a	415K	361K	-56.45M	-56.72M	-57.1M	361K	-57.59M	-58.05M	363K	363K	31K	61K	93K
Receivables	2.91M	2.2M	26.25M	402K	267K	15.05M	312K	675K	218K	800K	50K	433K	152K	975K	92K	659K	688K
Inventory	n/a	n/a	n/a	n/a	-868K	-622K	-406K	-303K	-598K	n/a	n/a	-335K	n/a	n/a	-341K	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.76M	n/a	n/a
Total Current Assets	152.13M	171.99M	187.59M	180.54M	109.87M	125.15M	86.18M	99.15M	111.69M	128.09M	147.6M	158.38M	177.06M	202.63M	195.38M	202.8M	220.49M
Property-Plant & Equipment	7.95M	8.09M	5.83M	6.16M	6.58M	6.88M	6.03M	6.3M	6.68M	7.07M	7.18M	7.63M	7.68M	8.03M	7.63M	7.86M	7.04M
Goodwill & Intangibles	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	50.42M	n/a	n/a	n/a
Total Long-Term Assets	58.95M	58.92M	56.66M	56.99M	57.41M	57.66M	56.81M	57.08M	57.46M	57.84M	57.95M	58.41M	58.46M	58.81M	8.02M	8.29M	7.47M
Total Assets	211.08M	230.91M	244.25M	237.53M	167.28M	182.81M	142.99M	156.23M	169.15M	185.94M	205.56M	216.79M	235.52M	261.44M	203.4M	211.09M	227.96M
Account Payables	2.39M	2.66M	1.42M	1.44M	2.84M	1.68M	1.48M	1.35M	1.14M	929K	1.52M	337K	501K	2M	215K	317K	370K
Deferred Revenue	84.68M	85.06M	85.98M	86.51M	74K	138K	338K	430K	415K	587K	524K	425K	266K	717K	123K	348K	580K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	99.25M	100.84M	100.99M	100.53M	14.12M	13.58M	11.71M	11.15M	10.76M	11.48M	13.6M	11.92M	11.91M	20.03M	14.22M	11.85M	11.13M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	8.94M	8.84M	5.92M	11.04M	5.82M	5.77M	3.77M	3.77M	3.35M	3.21M	n/a	n/a	7.28M	7.1M	7.96M	7.83M	7.71M
Total Long-Term Liabilities	17.04M	17.8M	13.1M	13.58M	8.48M	8.6M	5.61M	5.75M	5.46M	5.47M	1.9M	2.05M	9.48M	9.44M	9.95M	9.96M	9.42M
Total Liabilities	116.28M	118.64M	114.08M	114.11M	22.6M	22.17M	17.32M	16.9M	16.21M	16.95M	15.5M	13.97M	21.39M	29.46M	24.18M	21.81M	20.54M
Total Debt	5.17M	5.43M	3.08M	3.23M	3.33M	3.5M	2.39M	2.53M	2.67M	2.8M	2.48M	2.63M	2.77M	2.91M	2.57M	2.7M	2.15M
Common Stock	2.23M	2.23M	2.22M	2.21M	2.09M	2.09M	1.8M	1.8M	1.8M	1.8M	1.8M	1.8M	1.79M	1.79M	1.59M	1.54M	1.54M
Retained Earnings	-386.21M	-368.24M	-348.94M	-354.61M	-332.56M	-316.2M	-310.49M	-296.06M	-280.11M	-264.01M	-242.99M	-230.17M	-218.79M	-200.94M	-181.66M	-167.07M	-148.77M
Comprehensive Income	-1K	-5K	-24K	-35K	-35K	-51K	5K	-6K	2K	10K	72K	49K	0.00	0.00	0.00	0.00	0.00
Shareholders Equity	94.8M	112.27M	130.16M	123.42M	144.68M	160.64M	125.66M	139.33M	152.94M	168.99M	190.05M	202.81M	214.13M	231.98M	179.22M	189.28M	207.42M
Total Investments	126.24M	129.63M	125.89M	123.56M	47.81M	24.91M	48.36M	53.36M	48.36M	91.36M	96.36M	91.36M	116.36M	116.36M	95.36M	95.36M	65.33M